The Effect of Nalbuphine Extended-Release (NAL ER) on Cough in Participants With Refractory Chronic Cough (RCC)

NCT07671924 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Refractory Chronic Cough

Interventions

DRUG: NAL ER
DRUG: Placebo

Sponsor

Trevi Therapeutics